Hotline:4006-508-908

CFDA approved the Registration Licenses of PIK3CA and BRAF Mutation Detection Kits from ACCB

Source:Date:2015-06-08Views:1114

    The Chinese Food and Drug Administration (CFDA) has approved the Registration Licenses of Human PIK3CA and BRAF gene mutation detection kits (fluorescent PCR) from Beijing ACCB Biotech Company Limited, and their license number is 2014 3401044 and 2014 3401045, respectively.
    Determination of PIK3CA and BRAF mutation detection kits is favor in clinical management of EGFR tyrosine kinase inhibitors and cetuximab in cancer patient target therapies, respectively. 

Beijing ACCB Biotech Company Limited     All Rights Reserved Jing ICP Registration No05018742-1     Site map     

友情链接:鸿利彩票  永利彩票  永利彩票  迅雷彩票官网  迅雷彩票  

免责声明: 本站资料及图片来源互联网文章,本网不承担任何由内容信息所引起的争议和法律责任。所有作品版权归原创作者所有,与本站立场无关,如用户分享不慎侵犯了您的权益,请联系我们告知,我们将做删除处理!